KalVista Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY	FY 2023
Period Ending	Jun '26 Jun 9, 2026	Dec '25 Dec 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Mar '24 Mar 31, 2024	Apr '23 Apr 30, 2023
Market Capitalization	1,438	816	685	479	500	291
Market Cap Growth	153.62%	19.24%	42.97%	-4.30%	71.67%	-6.71%
Enterprise Value	1,437	790	538	411	432	128
Last Close Price	27.00	16.15	13.77	11.35	11.86	8.53
PS Ratio	12.56	11.09	-	-	-	-
PB Ratio	-	-301.11	7.18	2.32	-	1.81
P/TBV Ratio	-	-	7.18	2.32	-	1.81
EV/Sales Ratio	12.55	10.73	-	-	-	-
Debt / Equity Ratio	-14.47	-104.83	1.18	0.04	-	0.05
Net Debt / Equity Ratio	0.04	5.90	-1.14	-0.98	-	-0.88
Net Debt / EBITDA Ratio	0.01	0.10	0.58	1.45	-	1.28
Net Debt / FCF Ratio	0.01	0.13	0.71	2.28	-	1.85
Quick Ratio	4.97	5.43	5.22	9.70	-	11.18
Current Ratio	5.17	5.58	5.35	9.90	-	11.46
Return on Equity (ROE)	-	-	-121.50%	-68.90%	-	-53.69%
Return on Assets (ROA)	-	-	-48.34%	-41.94%	-	-35.80%
Return on Capital Employed (ROCE)	-52.20%	-59.80%	-91.40%	-66.10%	-	-65.90%
Earnings Yield	-9.46%	-20.13%	-26.80%	-26.45%	-	-31.88%
FCF Yield	-6.38%	-15.31%	-22.40%	-18.64%	-	-26.23%
Buyback Yield / Dilution	-9.26%	-8.49%	-34.98%	-	-	-13.96%

SEC Filings: 10-K · 10-Q